Mots-clés
Cannabis; Non épileptique; Psychogène; Saisie; Stress.
Droits d’auteur © 2016 Elsevier Inc. Tous droits réservés.
Détails de l'étude :
Références
-
Profils de réponse au traitement dans l’épilepsie nouvellement diagnostiquée.Neurologie. 2012; 78: 1548-1554
-
Les cannabinoïdes dans le traitement de l’épilepsie.N Engl J Med. 2015; 373: 1048-1058
-
Marijuana, endocannabinoïdes et épilepsie : potentiel et défis pour une intervention thérapeutique améliorée.Exp Neurol. 2013; 244: 43-50
-
Cannabinoïdes pour l’épilepsie.Cochrane Database Syst Rev. 2014; 3 CD009270
-
Revue systématique: efficacité et innocuité de la marijuana médicale dans certains troubles neurologiques: rapport du sous-comité d’élaboration des lignes directrices de l’American Academy of Neurology.Neurologie. 2014; 82: 1556-1563
-
La marijuana: un traitement de l’épilepsie consacré mais non testé.Can J Neurol Sci. 2015; 42: 88-91
-
Déclaration parentale de la réponse aux extraits oraux de cannabis pour le traitement de l’épilepsie réfractaire.Comportement de l’épilepsie. 2015; 45: 49-52
-
Cannabis.dans: Gupta S. CNN. 2013 ([voir la promotion vidéo du programme à http://www.cnn.com/videos/bestoftv/2013/08/05/gupta-weed-promo.cnn])
-
Cannabidiol chez les patients atteints d’épilepsie résistante au traitement: un essai interventionnel ouvert.Lancet Neurol. 2016; 15: 270-278
-
GW pharmaceuticals annonce des résultats positifs de l’étude pivot de phase 3 pour l’épidiolex (cannabidiol).Date: Mars 2016
-
GW pharmaceuticals announces positive phase 3 pivotal trial results for epidiolex (cannabidiol) in treatment of Lennox–Gastaut syndrome.Date: June 2016
-
Drug and health products: medical use of marihuana. About the marijuana medical access program. [Updated 2013 Jun 20].(Available from)
-
Medicinal marijuana for epilepsy: a case series study.Can J Neurol Sci. 2014; 41: 753-758
-
Minimum requirements for the diagnosis of psychogenic nonepileptic seizures: a staged approach: a report from the International League Against Epilepsy Nonepileptic Seizures Task Force.Epilepsia. 2013; 54: 2005-2018
-
Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.Epilepsia. 2014; 55: 791-802
-
Marijuana use and epilepsy: prevalence in patients of a tertiary care epilepsy center.Neurology. 2004; 62: 2095-2097
-
Cannabis users in the general Canadian population.Subst Use Misuse. 2000; 35: 301-311
-
Self-reported medical use of marijuana: a survey of the general population.CMAJ. 2000; 162: 1685-1686
-
Unconventional medicine in the United States. Prevalence, costs, and patterns of use.N Engl J Med. 1993; 328: 246-252
-
Use of complementary and alternative medicine in an urban county hospital epilepsy clinic.Epilepsy Behav. 2014; 34: 73-76
-
Cannabis and other illicit drug use in epilepsy patients.Eur J Neurol. 2014; 21: 167-170
-
Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy.Epilepsy Behav. 2013; 29: 574-577
-
Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: a potential role for infantile spasms and Lennox–Gastaut syndrome.Epilepsy Behav. 2015; 47: 138-141
-
Chronic administration of cannabidiol to healthy volunteers and epileptic patients.Pharmacology. 1980; 21: 175-185
-
Alcohol and marijuana: effects on epilepsy and use by patients with epilepsy.Epilepsia. 2001; 42: 1266-1272
-
Cannabis, cannabidiol, and epilepsy—from receptors to clinical response.Epilepsy Behav. 2014; 41: 277-282
-
Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.Arch Gen Psychiatry. 2009; 66: 95-105
-
Medical marijuana: review of the science and implications for developmental–behavioral pediatric practice.J Dev Behav Pediatr. 2015; 36: 115-123
-
Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: systematic review and meta-analysis.Epilepsia. 2010; 51: 7-26
-
Are cannabidiol and Delta(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.Br J Pharmacol. 2015; 172: 737-753
-
Cannabidivarin is anticonvulsant in mouse and rat.Br J Pharmacol. 2012; 167: 1629-1642
-
Fewer specialists support using medical marijuana and CBD in treating epilepsy patients compared with other medical professionals and patients: result of Epilepsia's survey.Epilepsia. 2015; 56: 1-6
-
Attitudes des médecins de famille du Colorado à l’égard de la marijuana médicale.J Am Board Fam Med. 2013; 26: 52-60
-
Cannabidiol pour l’épilepsie: essayer de voir à travers la brume.Lancet Neurol. 2016; 15: 235-237